Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Discover why keeping cash can be a safer alternative to bank savings. Make informed decisions about your financial security.
25,924 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
Five stalwart Dividend Aristocrats continue to anchor retirement portfolios with rising payouts, steady cash flow, an...
A standout earnings beat pushed Clear Secure stock higher on Wednesday as revenue, user growth, and guidance surprise...
As the SpaceX IPO news cycle heats up, investors want real guidance. This article breaks down what to look for in the...
Asana has fallen from pandemic highs, but buying the dip isn’t a guaranteed win. This guide explains the risks, what ...
Long-term success in the stock market isn’t about chasing the next hot tip. It’s about a disciplined plan built on lo...
When the broader market stumbled, CoreWeave stock surged higher this week thanks to AI cloud demand and solid custome...
Curious about XRP’s future? This article lays out a practical 5-year forecast with three scenarios and clear steps yo...
Gold prices surged last year and pulled back from a record. This guide helps you decide if you should gold while it's...
A routine check request at a local credit union led to an account freeze and a wider fraud investigation. This articl...
A Vanguard ETF is delivering eye-popping gains in 2026, outpacing the S&P 500. But how long can this momentum last wh...